Navigation Links
Cancer Risk is High Among HIV/AIDS and Kidney Transplant Patients

Researchers have found that HIV/AIDS and kidney transplant patients are at higher risk of developing 20 different types of cancer than the general population.

The study was conducted by a team of researchers led by Professor Andrew Grulich at the University of New South Wales National Centre in HIV Epidemiology and Clinical Research (NCHECR).

As part of the study, scientists compared cancer rates between these HIV/AIDS and kidney transplant patients with the general population.

The study found that HIV/AIDS patients were 11 times more likely to develop Hodgkins lymphoma, a cancer associated with Epstein Barr Virus, while those who had a transplant were 4 times at a higher risk.

The study also found that in both these populations, cancers associated with human papilloma virus, from cervical cancer to cancers of the mouth, penis and anus were significantly increased.

One of the three cancers that were already linked with HIV is Kaposis sarcoma. In HIV population, there was a 3,640-fold increased likelihood for patients to develop the disease.

This research showed that transplant patients were 208 times more likely to develop the cancer than the general population.

Researchers suggested that one common thing in both the groups was immune deficiency, which was responsible for the increased risk of developing cancer.

The only thing that people with AIDS and transplant recipients share is immune deficiency, otherwise their risk factors for cancer differ markedly, the Lancet quoted Professor Grulich, as saying.

In other cancers, which are not linked with viruses, such as breast and prostate cancer, both groups had similar rates to the general population, he said.


'"/>




Page: 1

Related medicine news :

1. Fibroids unlikely to Turn Cancerous
2. Virus Level could Predict Cervical Cancer Risk
3. Cancer Doctors Okays Controversial Prostate Therapy
4. Potential New Cancer Gene Identified
5. Consensus on "Combination Therapy" for Breast Cancer
6. Cancers of Colon & Rectum linked to Cigarette Smoking
7. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
8. The Cancer Rumour mill working over time
9. Cancer drugs in development nearly doubled since 1995
10. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
11. Cancer patients turning to Internet for information
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/8/2016)... ... December 08, 2016 , ... Coffey Agencies, a ... and commercial clients in the northern Alabama and Georgia regions, is embarking on ... 1977, Nobis Works has built a network of support and education facilities to ...
(Date:12/7/2016)... , ... December 07, 2016 , ... DrugDev ... announcement that it is one of the early adopters completing EU-U.S. Privacy Shield Certification ... designed to provide companies on both sides of the Atlantic with a mechanism to ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... ... celebrating the passage of the most comprehensive mental health systems reform legislation in ... support of the President, and the commitment of our elected officials to improving ...
(Date:12/7/2016)... York, NY (PRWEB) , ... December 07, 2016 ... ... amounts of the drug in their bodies, a researcher at the Icahn School ... journal Pediatric Research. , The study found that when young children are exposed ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... of Smart Device Remote Control through a new partnership with Splashtop Inc. This ... strengthens its mobile solutions to help businesses maximize their uptime and productivity. , ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016 Henry Schein, Inc. (Nasdaq: ... care products and services to office-based dental, animal health and ... equity investment in Marrodent, one of Poland,s ... $32 million. This transaction was announced on August 30, 2016. ... Poland since 2014, and Marrodent marks ...
(Date:12/8/2016)... Dec 8, 2016 Research and Markets has announced ... report to their offering. ... , The report provides separate comprehensive ... , and Rest of World. Annual estimates and ... historic analysis is provided for these markets. Market data and analytics are ...
(Date:12/7/2016)... Dec. 7, 2016 "Lantus (Insulin Glargine) Biosimilar Clinical Trial & ... biosimilar version of Lantus drug in clinical pipeline. Currently 5 biosimilar version ... Japan , Kenya , Czech ... , China , Slovakia , ... 2 diabetes mellitus. The patent on Lantus expired in 2014. Lantus ...
Breaking Medicine Technology: